An observational study in Well-Being, Psychological, sponsored by Samuel Lunenfeld Research Institute, Mount Sinai Hospital. Completed at 1 site in Canada. Open to female participants aged 18 Years to 55 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-16.
Sponsored by Samuel Lunenfeld Research Institute, Mount Sinai Hospital · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 156 studies in Psychological Well-Being with a site in Canada — 45 open to participants now, 59 under way, 1 of them phase 3. Psychological Well-Being · Canada.
Among the 156 studies in Psychological Well-Being with a site in Canada, this one is the 11th largest by enrollment of the 27 observational ones that give a count, is one of 17 that started in 2025, is one of 27 observational ones, and was the 110th registered.
2,208 studies on the registry are indexed under Psychological Well-Being; 730 are open to participants now.
Browse Psychological Well-Being studies →45 of the 156 studies in Psychological Well-Being with a site in Canada are open now. Recruiting first, the newest first:
Samuel Lunenfeld Research Institute, Mount Sinai Hospital · Sites in Canada
Ages 18+ · Women only · Healthy volunteers
The Hospital for Sick Children · Sites in Canada
Ages 8–17
The Hospital for Sick Children · Sites in Canada
Ages 10–17
Trillium Health Partners · Sites in Canada
Ages 14+ · Healthy volunteers
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · Sites in Canada
Ages 16–35
A study can be open while its sites in Canada have not opened yet or have stopped. Only those recruiting at a site in Canada →
Of the 403 Psychological Well-Being studies recruiting now, 223 (55%) set no upper age limit and 155 (38%) stop at 75 or younger; 121 take children under 18; 206 take healthy volunteers.
This study: 18 Years to 55 Years · female · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
156 studies; the count open now beside each. This study's row is marked.
First in 2002; this study’s year is marked. 17 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 200 is below the median of 300 across 361 observational studies indexed under Psychological Well-Being.
Median enrollment 100 across the 128 interventional studies, 100 across the 27 observational. Of the 83 that completed or were terminated, 5 (6%) have results posted.
This tab as a report to print or save as PDF → With an account.
2 of 156 have an industry lead sponsor. The 10 most frequent:
Samuel Lunenfeld Research Institute, Mount Sinai Hospital is the lead sponsor of 138 studies on the registry; 17 are open to participants now.
Samuel Lunenfeld Research Institute, Mount Sinai Hospital has 6 studies filed under Psychological Well-Being — fewer than ten, so there is no comparison to draw.
18 of the studies in Psychological Well-Being with a site in Canada that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07313657Bruyère Health Research Institute.Improving Care and Mental Well-Being for Adults With Heart Failure | 2026-11-30 |
| NCT05543720University Health Network, TorontoEvaluation of Nurse-led Integrated Care of Complex Patients Facilitated By Telemonitoring: The SMaRT Study | 2026-12 |
| NCT07867106Samuel Lunenfeld Research Institute, Mount Sinai HospitalPatient Experiences of Intraoperative Discomfort During Cesarean Delivery Under Neuraxial Anesthesia | 2026-12 |
| NCT06455397Leslie E. RoosBuilding Emotional Awareness and Mental Health (BEAM) 2024-2027 | 2026-12 |
| NCT05793944University of British ColumbiaSmartMom: Teaching by Texting to Promote Health Behaviours in Pregnancy | 2026-12-31 |
Add all 18 to your calendar (.ics) → With an account.
Among the 156 studies in Psychological Well-Being with a site in Canada, from their registry updates:
This tab as a report to print or save as PDF → With an account.
There is no widely used, statistically validated assessment for physical and mental health for the short- to medium-term in a postpartum population. PROMIS-29 has been validated for the assessment of these factors in a generic population, but has not been specifically evaluated for use with postpartum women.
This study is a longitudinal, single center observational cohort study designed to evaluate the reliability of the Patient-Reported Outcomes Measurement Information System (PROMIS)-29 v2.1 survey in a postpartum population. PROMIS-29 is a survey designed to screen for pain, impairments in mood, physical function, and activities of daily living. While this survey has shown utility in other populations, it has yet to be assessed in an obstetric population. The investigators plan to recruit patients who are recently postpartum from vaginal or cesarean delivery to complete virtual surveys at defined time points (0, 2, 6, and 12 weeks after delivery). The investigators will subject survey data to statistical measures of validity and reliability comparing with contemporaneously collected surveys of established metrics for quality of life (WHOQoLBREF) and general (global) state of health (numerical rating score 1-100).
The hypothesis is that the PROMIS-29 v2.1 questionnaire is a statistically valid and reliable means of assessing physical and mental health in a postpartum population.
Patients who deliver vaginally or by scheduled cesarean section at Mount Sinai Hospital.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Patients who have vaginal deliveries with neuraxial labour analgesia.
Other: PROMIS-29 v2.1 (Patient-Reported Outcomes Measurement Information System) · Other: WHOQoLBREF (World Health Organization Quality of Life Brief Version) · Other: EQ-5D-3L1 (not an acronym)
Patients who have a scheduled cesarean delivery with neuraxial anesthesia.
Other: PROMIS-29 v2.1 (Patient-Reported Outcomes Measurement Information System) · Other: WHOQoLBREF (World Health Organization Quality of Life Brief Version) · Other: EQ-5D-3L1 (not an acronym)
PROMIS-29 is a survey designed to screen for pain, impairments in mood, physical function, and activities of daily living.
Also known as: Patient-Reported Outcomes Measurement Information System
The WHOQOL-BREF is a 26-item version of the 100-item WHOQOL-100 quality of life measure that addresses four quality of life domains: physical health, psychological health, social relationships and environment.
Also known as: World Health Organization Quality of Life Brief Version
The EQ-5D-3L1 is a generic measure of health status consisting of two parts. The first part assesses health in five dimensions: MOBILITY, SELFCARE, USUAL ACTIVITIES, PAIN / DISCOMFORT, ANXIETY/DEPRESSION. The second part of the questionnaire consists of a VAS on which the patient rates their perceived health from 0 (the worst imaginable health) to 100 (the best imaginable health).
Also known as: Global state of health numerical rating score 1-100
PROMIS-29 v2.1 (Patient-Reported Outcomes Measurement Information System) survey score
The PROMIS survey score at 24 hours postpartum
Time frame: 24 hours
WHOQoLBREF (World Health Organization Quality of Life Brief Version) survey score
The WHOQoLBREF survey score at 24 hours postpartum
Time frame: 24 hours
EQ-5D-3L1 (not an acronym) survey score
The EQ-5D-3L1 survey score at 24 hours postpartum
Time frame: 24 hours
PROMIS-29 v2.1 (Patient-Reported Outcomes Measurement Information System) survey score
The PROMIS survey score at 2 weeks postpartum
Time frame: 2 weeks
WHOQoLBREF (World Health Organization Quality of Life Brief Version) survey score
The WHOQoLBREF survey score at 2 weeks postpartum
Time frame: 2 weeks
EQ-5D-3L1 (not an acronym) survey score
The EQ-5D-3L1 survey score at 2 weeks postpartum
Time frame: 2 weeks
PROMIS-29 v2.1 (Patient-Reported Outcomes Measurement Information System) survey score
The PROMIS survey scores at 6 weeks postpartum
Time frame: 6 weeks
WHOQoLBREF (World Health Organization Quality of Life Brief Version) survey score
The WHOQoLBREF survey score at 6 weeks postpartum
Time frame: 6 weeks
EQ-5D-3L1 (not an acronym) survey score
The EQ-5D-3L1 survey score at 6 weeks postpartum
Time frame: 6 weeks
PROMIS-29 v2.1 (Patient-Reported Outcomes Measurement Information System) survey score
The PROMIS survey score at 12 weeks postpartum
Time frame: 12 weeks
WHOQoLBREF (World Health Organization Quality of Life Brief Version) survey score
The WHOQoLBREF survey score at 12 weeks postpartum
Time frame: 12 weeks
EQ-5D-3L1 (not an acronym) survey score
The EQ-5D-3L1 survey score at 12 weeks postpartum
Time frame: 12 weeks
Plan to share: No
No publications or documents are linked to this record.
Ran from Jul 2025 to primary completion in Jan 2026, 6 months.
Of 152 non-industry observational studies under Psychological Well-Being, half reached primary completion within 30 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 155. This study's 6 months is below that.
Counting every sponsor, half of 161 studies reached it within 30 months; a quarter within 13 and three quarters within 155.
Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 16, 2026: primary completion Jul 2026 → Jan 2026 and completion Jul 2026 → Apr 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Samuel Lunenfeld Research Institute, Mount Sinai Hospital →